Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128b4 · Date: 20250220 · State: TX
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,197
Total Claims
$202K
Drug Cost
107
Beneficiaries
$1,886
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-38%
Opioid rate vs peers
1.6% vs 2.6% avg
+77%
Cost per patient vs peers
$1,886 vs $1,068 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.6%
Opioid Rate
35
Opioid Claims
$1,076
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 1,944 claims · $58K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 22 | $20K |
| Liraglutide | 13 | $15K |
| Evolocumab | 12 | $7,208 |
| Umeclidinium Brm/Vilanterol Tr | 14 | $6,963 |
| Aliskiren Hemifumarate | 19 | $6,173 |
| Telmisartan/Hydrochlorothiazid | 37 | $4,284 |
| Rosuvastatin Calcium | 145 | $2,764 |
| Colestipol Hcl | 14 | $2,647 |
| Telmisartan | 68 | $2,407 |
| Estradiol/Norethindrone Acet | 14 | $2,381 |
| Ezetimibe/Simvastatin | 11 | $2,022 |
| Levothyroxine Sodium | 104 | $1,688 |
| Valsartan/Hydrochlorothiazide | 23 | $1,613 |
| Desvenlafaxine Succinate | 16 | $1,492 |
| Pantoprazole Sodium | 64 | $1,480 |
Prescribing Profile
Patient Profile
73
Avg Age
42%
Female
0.89
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About